Colgate-Palmolive Company

(New York Stock Exchange)
Slightly Bullish +25

Is Colgate-Palmolive (CL) Still A Bargain On Cash Flow?

πŸ“ˆ Colgate-Palmolive has returned 35.5% to shareholders over the past five years, demonstrating a strong cash engine supported by steady consumer demand.

πŸ’° The company generated approximately $3.85 billion in latest twelve-month free cash flow, providing a solid anchor for valuation models.

πŸ“‰ A DCF analysis indicates that projected future cash flows support an intrinsic worth meaningfully above the current share price of US$89.95.

πŸš€ The bullish narrative attributes potential upside to expansion and premiumization of core oral care lines like Colgate Total and Optic White Pro Series.

⚠️ The bearish narrative warns that normalizing margins while leaving future multiples at GAAP-derived figures could overstate fair value by roughly 45%.

🏷️ Simply Wall St's community analysis concludes that the bullish view sees more upside in the current price than the cautious, fair value perspective.

Bullish Signals
  • Colgate-Palmolive has delivered a solid run over the past few years with a 35.5% shareholder return over five years.
  • The company relies on steady consumer demand and strong cash conversion from household and personal care brands to support consistent reinvestment and payouts.
  • A DCF model based on $3.85 billion in latest twelve-month free cash flow suggests the stock is undervalued relative to its future cash generation potential.
  • The bullish narrative identifies 9% undervaluation driven by expansion and premiumization of core oral care lines like Colgate Total and Optic White Pro Series.
Risk Factors
  • A cautious valuation view suggests the stock is roughly fairly valued, noting that double-counting margin adjustments could overstate fair value by roughly 45%.
  • The business profile is that of a mature consumer products company where growth is expected to be gradual rather than aggressive step changes.
Full Analysis
Colgate-Palmolive (CL) is currently trading at approximately US$89.95 per share, a price point that analysts are evaluating against the company's robust historical cash flow performance. Over the past five years, the business has returned 35.5% to shareholders, driven by steady consumer demand and strong cash conversion capabilities inherent in its household and personal care portfolio. A Discounted Cash Flow (DCF) analysis utilizing a latest twelve-month free cash flow of roughly $3.85 billion suggests that the company's intrinsic value is meaningfully higher than its current market price. The model projects gradual growth in free cash flow over the coming decade, fitting the profile of a mature consumer products business where reliability of cash generation is paramount. Simply Wall St presents two distinct valuation narratives for CL: a bullish case suggesting the stock is 9% undervalued due to potential pricing power and mix improvements from premium product lines like Optic White Pro Series; conversely, a bearish or neutral case argues the stock is roughly fairly valued, warning against double-counting margin adjustments which could otherwise overstate fair value by approximately 45%.